ArticleAmerican journal of obstetrics & gynecology MFM2026
Trends in postpartum hemorrhage, associated risk factors, and severe maternal outcomes in a multihospital health system, 2016-2023: a retrospective cohort study.
Article in American journal of obstetrics & gynecology MFM, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundReported increases in postpartum hemorrhage (PPH) raise concerns for maternal risk and resource needs, but contemporary multicenter trends and severe outcomes remain uncertain.
objectiveTo quantify trends in PPH and severe PPH and identify factors associated with PPH to inform hemorrhage surveillance and preparedness. STUDY
designRetrospective cohort of all deliveries across eight hospitals (2 tertiary, 6 community) in a U.S. health system (2016-2023). PPH was defined as blood loss ≥1000 mL or red blood cell transfusion within 24 hours, and severe PPH as PPH plus ≥1 severe morbidity indicator. Temporal trends were evaluated using logistic regression. Risk-factor associations were estimated using modified Poisson regression with robust standard errors clustered by maternal identifier.
resultsAmong 115,087 deliveries, PPH increased from 8.1% to 10.4% (absolute increase, 2.3 percentage points; P for trend <.001), and severe PPH increased from 0.9% to 1.3% (absolute increase, 0.4 percentage points; P for trend <.001). Labor induction increased (24.0% to 37.2%), as did hypertensive disorders, higher obstetric comorbidity, and prior PPH. PPH was most strongly associated with placenta accreta spectrum (aRR, 3.51; 95% CI, 3.26-3.78), multiple gestation (aRR, 2.08; 95% CI, 1.96-2.21), operative vaginal delivery (aRR, 2.03; 95% CI, 1.84-2.25), and prolonged second stage (aRR, 1.76; 95% CI, 1.67-1.84). Among PPH cases, intensive care unit admission occurred in 2.0%, hysterectomy in 2.3%, and maternal death in 0.2%.
conclusionIn this multicenter network, PPH and severe PPH increased from 2016 to 2023, while severe outcomes among PPH cases remained uncommon. These data provide benchmarks for hemorrhage surveillance, preparedness, and resource planning across delivery settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.